Evidence map›Paper›PMID 38775898›Full record

ArticleVeterinary research communications2024

Effects of a multi-strain Bacillus probiotic on the intestinal microbiome, haemato-immunology, and growth performance of Nile tilapia.

José Victor Safadi Ferrarezi, Marco Shizuo Owatari, Mateus Aranha Martins, Lúvia de Souza Sá, Scheila Anelise Pereira Dutra, Hugo Mendes de Oliveira, Thiago Soligo, Maurício Laterça Martins, José Luiz Pedreira Mouriño

Abstract read
PubMed Publisher
In one paragraph

Article in Veterinary research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

José Victor Safadi FerrareziAQUOS-Aquatic Organisms Health Laboratory, Aquaculture Department, Center of Agrarian Sciences (CCA), Federal University of Santa Catarina (UFSC), Rodovia Admar Gonzaga, 1346, CEP 88034-000, Florianópolis, SC, Brazil.
Marco Shizuo OwatariAQUOS-Aquatic Organisms Health Laboratory, Aquaculture Department, Center of Agrarian Sciences (CCA), Federal University of Santa Catarina (UFSC), Rodovia Admar Gonzaga, 1346, CEP 88034-000, Florianópolis, SC, Brazil. owatarimarco@hotmail.com.
Mateus Aranha MartinsLCM - Marine Shrimp Laboratory, Aquaculture Department, Federal University of Santa Catarina (UFSC), Serv. Beco dos Coroas, 503, CEP 88061-600, Florianópolis, SC, Brazil.
Lúvia de Souza SáAQUOS-Aquatic Organisms Health Laboratory, Aquaculture Department, Center of Agrarian Sciences (CCA), Federal University of Santa Catarina (UFSC), Rodovia Admar Gonzaga, 1346, CEP 88034-000, Florianópolis, SC, Brazil.
Scheila Anelise Pereira DutraLCM - Marine Shrimp Laboratory, Aquaculture Department, Federal University of Santa Catarina (UFSC), Serv. Beco dos Coroas, 503, CEP 88061-600, Florianópolis, SC, Brazil.
Hugo Mendes de OliveiraAQUOS-Aquatic Organisms Health Laboratory, Aquaculture Department, Center of Agrarian Sciences (CCA), Federal University of Santa Catarina (UFSC), Rodovia Admar Gonzaga, 1346, CEP 88034-000, Florianópolis, SC, Brazil.
Thiago SoligoDSM - Nutritional Products Costa Rica, Industrial Park Z, Santo Domingo de Heredia, 40301, Heredia, Costa Rica.
Maurício Laterça MartinsAQUOS-Aquatic Organisms Health Laboratory, Aquaculture Department, Center of Agrarian Sciences (CCA), Federal University of Santa Catarina (UFSC), Rodovia Admar Gonzaga, 1346, CEP 88034-000, Florianópolis, SC, Brazil.
José Luiz Pedreira MouriñoAQUOS-Aquatic Organisms Health Laboratory, Aquaculture Department, Center of Agrarian Sciences (CCA), Federal University of Santa Catarina (UFSC), Rodovia Admar Gonzaga, 1346, CEP 88034-000, Florianópolis, SC, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 301524/2017-3; 306635/2018-6 and 155524/2018-6Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001
6 · The paper itself

Abstract

The study evaluated dietary supplementation with a feed additive composed of multi-strain Bacillus for Nile tilapia Oreochromis niloticus. In vitro and in vivo assays employing culture-based microbiological methods and metagenomics were performed. Additionally, the study assessed the haemato-immunology, intestinal microbiome, and growth performance of the animals. For this, 30 juvenile Nile tilapia were used in the in vitro assay and 180 (60 + 120) in the in vivo assays. In the in vitro assay, we found evidence of adhesion of the probiotic bacteria to the intestinal mucus of fish, corroborated in the 15-day in vivo assay, in which the count of B. licheniformis was significantly higher in fish fed with probiotic when compared to fish of the control group. Furthermore, in the 50-day in vivo trial, a metagenomic analysis provided evidence for the modulation of the intestine microbiome of Nile tilapia by dietary supplementation of the probiotic. In addition, there was an increase in species richness, higher abundance of potentially probiotic autochthonous species and a lower abundance of Aeromonas sp. when the animals were fed the supplemented diet. Finally, no significant differences were observed in growth performance and haemato-immunological analyses, suggesting no harm to fish health when the product was supplemented for 15 and 50 days. The in vitro results indicate that the multi-strain probiotics were able to adhere to the intestinal mucus of Nile tilapia. Additionally, a modulation of the intestinal microbiome was evidenced in the in vivo assay.

Indexed as

Animal FeedBacillusCichlidsDietGastrointestinal MicrobiomeProbioticsAnimalsDietary SupplementsAeromonasHaematologyImmunologyMetagenomicsMicrobiologyα-diversity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.